Ameriprise
CSCI

Ameriprise’s COSCIENS Biopharma Inc. Common Stock CSCI Stock Holding History

Ameriprise’s Portfolio CSCI Stock Details CSCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-2
Closed -$7K – 3967
2015
Q2 		$7K Sell
2
-2
-50% -$8.43K ﹤0.01% 4005
2015
Q1 		$23K Hold
4
– – ﹤0.01% 3760
2014
Q4 		$26K Buy
+4
New +$33.6K ﹤0.01% 3656
2014
Q3 		– Hold
0
– – – 5431
2014
Q2 		– Hold
0
– – – 5669
2014
Q1 		– Hold
0
– – – 5414
2013
Q4 		– Hold
0
– – – 5434
2013
Q3 		– Hold
0
– – – 5511

Other funds holding CSCI

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TCM
Tenor Capital Management New York $6.49B AUM 3.01% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Ameriprise's CSCI Position: Q3 2015 in Review

Ameriprise sold out of COSCIENS Biopharma Inc. Common Stock (CSCI) in Q3 2015, closing a stake of 2 shares — an estimated $7K sold.

Ameriprise first reported a position in CSCI in Q4 2014 and held it in 3 quarters. The position peaked at $26K in Q4 2014. 16 funds tracked by Wall St. Rank hold CSCI as of Q3 2015.

  • Ameriprise reported no remaining COSCIENS Biopharma Inc. Common Stock position as of Q3 2015 after selling out during the quarter.
  • Ameriprise sold 2 COSCIENS Biopharma Inc. Common Stock shares in Q3 2015, an estimated $7K.
  • Ameriprise first reported a position in COSCIENS Biopharma Inc. Common Stock in Q4 2014 and held it in 3 quarters.
  • Ameriprise's COSCIENS Biopharma Inc. Common Stock position peaked at $26K in Q4 2014.
  • 16 funds tracked by Wall St. Rank held COSCIENS Biopharma Inc. Common Stock as of Q3 2015.

Based on Ameriprise's 13F filing for Q3 2015, filed 12 Nov 2015.